نتایج جستجو برای: روش mds

تعداد نتایج: 376977  

Journal: :Applied and Computational Harmonic Analysis 2021

Multidimensional Scaling (MDS) is a classical technique for embedding data in low dimensions, still widespread use today. In this paper we study MDS modern setting - specifically, high dimensions and ambient measurement noise. We show that as the noise level increases, suffers sharp breakdown depends on dimension level, derive an explicit formula point case of white then introduce MDS+, simple ...

Journal: :Cancer cell 2014
Petter S Woll Una Kjällquist Onima Chowdhury Helen Doolittle David C Wedge Supat Thongjuea Rikard Erlandsson Mtakai Ngara Kristina Anderson Qiaolin Deng Adam J Mead Laura Stenson Alice Giustacchini Sara Duarte Eleni Giannoulatou Stephen Taylor Mohsen Karimi Christian Scharenberg Teresa Mortera-Blanco Iain C Macaulay Sally-Ann Clark Ingunn Dybedal Dag Josefsen Pierre Fenaux Peter Hokland Mette S Holm Mario Cazzola Luca Malcovati Sudhir Tauro David Bowen Jacqueline Boultwood Andrea Pellagatti John E Pimanda Ashwin Unnikrishnan Paresh Vyas Gudrun Göhring Brigitte Schlegelberger Magnus Tobiasson Gunnar Kvalheim Stefan N Constantinescu Claus Nerlov Lars Nilsson Peter J Campbell Rickard Sandberg Elli Papaemmanuil Eva Hellström-Lindberg Sten Linnarsson Sten Eirik W Jacobsen

Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which different cancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenito...

2012
Zhigang Zhao Zhenling Wang Qiubai Li Weiming Li Yong You Ping Zou

Myelodysplastic syndrome (MDS) are a group of progressive, clonal, neoplastic bone marrow disorders characterized by hematopoietic stem cell dysregulation and abnormalities in the immune system. Mesenchymal stem cells (MSC) have gained further interests after the demonstration of an immunoregulatory role. Nevertheless, the immunoregulatory function of MDS bone marrow derived MSC (MDS-MSC) remai...

Journal: :Blood 2003
Takafumi Matsushima Hiroshi Handa Akihiko Yokohama Jun Nagasaki Hiromi Koiso Yoshitora Kin Yoko Tanaka Tohru Sakura Norifumi Tsukamoto Masamitsu Karasawa Katsuhiko Itoh Hisami Hirabayashi Morio Sawamura Shogo Shinonome Shun-ichi Shimano Shuichi Miyawaki Yoshihisa Nojima Hirokazu Murakami

By retrospectively analyzing 288 patients with de novo myelodysplastic syndrome (MDS), we sought to determine the prevalence and clinical characteristics of bone marrow eosinophilia and basophilia that were detected at presentation. Bone marrow eosinophilia and basophilia were defined as a differential count of each cell type exceeding 5.0% and 1.0%, respectively. Of 288 patients with MDS, 36 (...

Journal: :[Rinsho ketsueki] The Japanese journal of clinical hematology 2015
Takahiro Suzuki

Myelodysplastic syndromes (MDS) are myeloid clonal disorders presumably induced by genetic mutations in immature hematopoietic cells. According to the international prognostic scoring system (IPSS or IPSS-R), patients are classified into two groups: lower-risk MDS (LR-MDS) and higher-risk MDS (HR-MDS). A majority of LR-MDS patients manifest refractory cytopenias due to inefficient hematopoiesis...

2016
James Taggart Tzu-Chieh Ho Elianna Amin Haiming Xu Trevor S Barlowe Alexendar R Perez Benjamin H Durham Patrick Tivnan Rachel Okabe Arthur Chow Ly Vu Sun Mi Park Camila Prieto Christopher Famulare Minal Patel Christopher J Lengner Amit Verma Gail Roboz Monica Guzman Virginia M Klimek Omar Abdel-Wahab Christina Leslie Stephen D Nimer Michael G Kharas

Myelodysplastic syndromes (MDS) are driven by complex genetic and epigenetic alterations. The MSI2 RNA-binding protein has been demonstrated to have a role in acute myeloid leukaemia and stem cell function, but its role in MDS is unknown. Here, we demonstrate that elevated MSI2 expression correlates with poor survival in MDS. Conditional deletion of Msi2 in a mouse model of MDS results in a rap...

2013
Nicolas Champagnat Pierre-Emmanuel Jabin

We study strong existence and pathwise uniqueness for stochastic differential equations in R with rough coefficients, and without assuming uniform ellipticity for the diffusion matrix. Our approach relies on direct quantitative estimates on solutions to the SDE, assuming Sobolev bounds on the drift and diffusion coefficients, and L bounds for the solution of the corresponding Fokker-Planck PDE,...

2004
Pascal Junod Serge Vaudenay

Although linear perfect diffusion primitives, i.e. MDS matrices, are widely used in block ciphers, e.g. AES, very little systematic work has been done on how to find “efficient” ones. In this paper we attempt to do so by considering software implementations on various platforms. These considerations lead to interesting combinatorial problems: how to maximize the number of occurrences of 1 in th...

2003
Takafumi Matsushima Hiroshi Handa Akihiko Yokohama Jun Nagasaki Hiromi Koiso Yoshitora Kin Yoko Tanaka Tohru Sakura Norifumi Tsukamoto Masamitsu Karasawa Katsuhiko Itoh Hisami Hirabayashi Morio Sawamura Shogo Shinonome Shun-ichi Shimano Shuichi Miyawaki Yoshihisa Nojima Hirokazu Murakami

By retrospectively analyzing 288 patients with de novo myelodysplastic syndrome (MDS), we sought to determine the prevalence and clinical characteristics of bone marrow eosinophilia and basophilia that were detected at presentation. Bone marrow eosinophilia and basophilia were defined as a differential count of each cell type exceeding 5.0% and 1.0%, respectively. Of 288 patients with MDS, 36 (...

Journal: :American journal of clinical pathology 2008
Sepideh Maftoun-Banankhah Atousa Maleki Nitin J Karandikar Arnaldo A Arbini Franklin S Fuda Huan-You Wang Weina Chen

Diagnosis of myelodysplastic syndromes (MDS) could be difficult. We explored the usefulness of the enumeration of maturing B-lineage precursors (hematogones) by multiparameter flow cytometric analysis in the diagnosis of MDS in bone marrow (BM) specimens. We evaluated 111 MDS, 120 non-MDS (most with cytopenias; control group 1), and 41 noncytopenic lymphoma staging BM (control group 2) specimen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید